The cabergoline-resistant prolactinoma patient: new challenges

J Clin Endocrinol Metab. 2008 Dec;93(12):4643-5. doi: 10.1210/jc.2008-2244.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adult
  • Cabergoline
  • Dopamine Agonists / administration & dosage
  • Dopamine Agonists / adverse effects
  • Dopamine Agonists / therapeutic use*
  • Drug Resistance
  • Echocardiography
  • Ergolines / administration & dosage
  • Ergolines / adverse effects
  • Ergolines / therapeutic use*
  • Female
  • Heart Valve Diseases / chemically induced
  • Heart Valve Diseases / diagnostic imaging
  • Humans
  • Male
  • Pituitary Neoplasms / drug therapy*
  • Prolactin / blood
  • Prolactinoma / drug therapy*
  • Receptors, Dopamine / drug effects
  • Young Adult

Substances

  • Dopamine Agonists
  • Ergolines
  • Receptors, Dopamine
  • Prolactin
  • Cabergoline